Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157–60.
PubMed
PubMed Central
Google Scholar
World Health Organization, WHO. Coronavirus disease 2019 (COVID-19): situation report, 51. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed 20 May 2020.
Google Scholar
Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020:108427. https://0-doi-org.brum.beds.ac.uk/10.1016/j.clim.2020.108427.
Nussbaumer-Streit B, Mayr V, Dobrescu AI, Chapman A, Persad E, Klerings I, et al. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database Syst Rev. 2020;4:CD013574. https://0-doi-org.brum.beds.ac.uk/10.1002/14651858.CD013574.
Article
PubMed
Google Scholar
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42.
Article
CAS
PubMed
Google Scholar
Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;31:e3319. https://0-doi-org.brum.beds.ac.uk/10.1002/dmrr.3319.
Article
Google Scholar
Cai H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med. 2020;8(4):e20. https://0-doi-org.brum.beds.ac.uk/10.1016/S2213-2600(20)30117-X.
Article
CAS
PubMed
PubMed Central
Google Scholar
La Vignera S, Cannarella R, Condorelli RA, Torre F, Aversa A, Calogero AE. Sex-specific SARS-CoV-2 mortality: among hormone-modulated ACE2 expression, risk of venous thromboembolism and hypovitaminosis D. Int J Mol Sci. 2020;21(8):E2948. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21082948.
Article
PubMed
Google Scholar
Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. 2020. Preprint at https://www.medrxiv.org/content/10.1101/2020.04.23.20076042v1.
Google Scholar
Williamson E, Walker AJ, Bhaskaran KJ, Bacon S, Bates C, Morton CE, et al. The OpenSAFELY Collaborative. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. 2020. Preprint at https://www.medrxiv.org/content/10.1101/2020.05.06.20092999v1.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.
Article
CAS
PubMed
Google Scholar
Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020; https://0-doi-org.brum.beds.ac.uk/10.3389/fpubh.2020.00152.
Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020. https://0-doi-org.brum.beds.ac.uk/10.1016/j.jaci.2020.04.006.
Zuin M, Rigatelli G, Zuliani G, Rigatelli A, Mazza A, Roncon L. Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis. J Infect. 2020. https://0-doi-org.brum.beds.ac.uk/10.1016/j.jinf.2020.03.059.
Klonoff DC, Umpierrez GE. COVID-19 in patients with diabetes: risk factors that increase morbidity. Metabolism. 2020;7:154224. https://0-doi-org.brum.beds.ac.uk/10.1016/j.metabol.2020.154224.
Article
CAS
Google Scholar
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020. https://0-doi-org.brum.beds.ac.uk/10.1001/jama.2020.6775.
Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm BO. Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol. 2020. https://0-doi-org.brum.beds.ac.uk/10.1038/s41574-020-0353-9.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
Article
Google Scholar
Kyrou I, Weickert MO, Randeva HS. Diagnosis and management of polycystic ovary syndrome (PCOS). In: Ajjan R, Orme SM, editors. Endocrinology and Diabetes Springer London; 2015. p. 99–113.
Google Scholar
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602–18.
Article
PubMed
PubMed Central
Google Scholar
Gibson-Helm M, Dokras A, Karro H, Piltonen T, Teede HJ. Knowledge and practices regarding polycystic ovary syndrome among physicians in Europe, North America, and internationally: an online questionnaire-based study. Semin Reprod Med. 2018;36(1):19–27.
Article
PubMed
Google Scholar
Dokras A, Saini S, Gibson-Helm M, Schulkin J, Cooney L, Teede H. Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome. Fertil Steril. 2017;107(6):1380–1386.e1.
Article
PubMed
Google Scholar
Kyrou I, Randeva HS, Tsigos C, Kaltsas G, Weickert MO. Clinical Problems Caused by Obesity. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth: MDText.com, Inc.; 2018. https://0-www-ncbi-nlm-nih-gov.brum.beds.ac.uk/books/NBK278973/. Accessed 20 May 2020.
Google Scholar
Randeva HS, Tan BK, Weickert MO, Lois K, Nestler JE, Sattar N, et al. Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev. 2012;33(5):812–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kahal H, Kyrou I, Tahrani AA, Randeva HS. Obstructive sleep apnoea and polycystic ovary syndrome: a comprehensive review of clinical interactions and underlying pathophysiology. Clin Endocrinol. 2017;87(4):313–9.
Article
CAS
Google Scholar
Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347–63.
Article
CAS
PubMed
Google Scholar
Kakoly N, Khomami M, Joham A, Cooray S, Misso M, Norman R, et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update. 2018;24(4):455–67.
Article
CAS
PubMed
Google Scholar
Magrone T, Magrone M, Jirillo E. Focus on receptors for coronaviruses with special reference to angiotensin-converting enzyme 2 as a potential drug target-a perspective. Endocr Metab Immune Disord Drug Targets. 2020. https://0-doi-org.brum.beds.ac.uk/10.2174/1871530320666200427112902.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dalpiaz P, Lamas A, Caliman I, Ribeiro R Jr, Abreu G, Moyses M, et al. Sex hormones promote opposite effects on ACE and ACE2 activity, hypertrophy and cardiac contractility in spontaneously hypertensive rats. PLoS One. 2015;10(5):e0127515. https://0-doi-org.brum.beds.ac.uk/10.1371/journal.pone.0127515.
Article
CAS
PubMed
PubMed Central
Google Scholar
Goren A, Vano-Galvan S, Wambier CG, McCoy J, Gomez-Zubiaur A, Moreno-Arrones OM, et al. A preliminary observation: male pattern hair loss among hospitalized COVID-19 patients in Spain–a potential clue to the role of androgens in COVID-19 severity. J Cosmet Dermatol. 2020. https://0-doi-org.brum.beds.ac.uk/10.1111/jocd.13443.
McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Sinclair R, Müller Ramos P, et al. Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19? J Cosmet Dermatol. 2020. https://0-doi-org.brum.beds.ac.uk/10.1111/jocd.13455.
Wambier CG, Goren A. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated. J Am Acad Dermatol. 2020. https://0-doi-org.brum.beds.ac.uk/10.1016/j.jaad.2020.04.032.
Wambier CG, Goren A, Vaño-Galván S, Ramos PM, Ossimetha A, Nau G, et al. Androgen sensitivity gateway to COVID-19 disease severity. Drug Dev Res. 2020. https://0-doi-org.brum.beds.ac.uk/10.1002/ddr.21688.
Quinn M, Shinkai K, Pasch L, Kuzmich L, Cedars M, Huddleston H. Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features. Fertil Steril. 2014;101(4):1129–34.
Article
CAS
PubMed
Google Scholar
Di Guardo F, Cerana MC, D'urso G, Genovese F, Palumbo M. Male PCOS equivalent and nutritional restriction: are we stepping forward? Med Hypotheses. 2019;126:1–3. https://0-doi-org.brum.beds.ac.uk/10.1016/j.mehy.2019.03.003.
Article
PubMed
Google Scholar
Cannarella R, Condorelli RA, Dall'Oglio F, La Vignera S, Mongioì LM, Micali G, et al. Increased DHEAS and decreased total testosterone serum levels in a subset of men with early-onset androgenetic alopecia: does a male PCOS-equivalent exist? Int J Endocrinol. 2020;2020:1942126. https://0-doi-org.brum.beds.ac.uk/10.1155/2020/1942126 eCollection 2020.
Article
PubMed
PubMed Central
Google Scholar
Schroeder M, Tuku B, Jarczak D, Nierhaus A, Bai T, Jacobsen H, et al. The majority of male patients with COVID-19 present low testosterone levels on admission to Intensive Care in Hamburg, Germany: a retrospective cohort study. 2020. Preprint at https://www.medrxiv.org/content/10.1101/2020.05.07.20073817v1.
Google Scholar
Kupferschmidt K. Preprints bring ‘firehose’ of outbreak data. Science. 2020;367(6481):963–4.
Article
CAS
PubMed
Google Scholar
Fagone P, Ciurleo R, Lombardo SD, Iacobello C, Palermo CI, Shoenfeld Y, et al. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies. Autoimmun Rev. 2020:102571. https://0-doi-org.brum.beds.ac.uk/10.1016/j.autrev.2020.102571.
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guo R, Zheng Y, Yang J, Zheng N. Association of TNF-alpha, IL-6 and IL-1beta gene polymorphisms with polycystic ovary syndrome: a meta-analysis. BMC Genet. 2015;16:5. https://0-doi-org.brum.beds.ac.uk/10.1186/s12863-015-0165-4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang Y, Che L, Zhang M, He J. Common cytokine polymorphisms and predisposition to polycystic ovary syndrome: a meta-analysis. Endocr J. 2020. https://0-doi-org.brum.beds.ac.uk/10.1507/endocrj.EJ19-0558.
Jing Y, Run-Qian L, Hao-Ran W, Hao-Ran C, Ya-Bin L, Yang G, et al. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod. 2020:gaaa030. https://0-doi-org.brum.beds.ac.uk/10.1093/molehr/gaaa030.
Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020:e33213321. https://0-doi-org.brum.beds.ac.uk/10.1002/dmrr.3321.
Aldridge RW, Lewer D, Katikireddi SV, Mathur R, Pathak N, Burns R, et al. Black, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data. Wellcome Open Res. 2020;5:88 https://0-doi-org.brum.beds.ac.uk/10.12688/wellcomeopenres.15922.1.
Article
PubMed
PubMed Central
Google Scholar
Pareek M, Bangash MN, Pareek N, Pan D, Sze S, Minhas JS, et al. Ethnicity and COVID-19: an urgent public health research priority. Lancet. 2020;395(10234):1421–2.
Article
CAS
PubMed
PubMed Central
Google Scholar
UK Office for National Statistics. Coronavirus (COVID-19) related deaths by ethnic group, England and Wales: 2 March 2020 to 10 April 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/coronavirusrelateddeathsbyethnicgroupenglandandwales/2march2020to10april2020. Accessed 20 May 2020.
Cook T, Kursumovic E, Lennane S. Exclusive: deaths of NHS staff from covid-19 analysed. Health Serv J. 2020; https://www.hsj.co.uk/exclusive-deaths-of-nhs-staff-from-covid-19-analysed/7027471.article. Accessed 20 May 2020.
Liverpool L. Why are ethnic minorities worse affected? New Sci. 2020;246(3279):11. https://0-doi-org.brum.beds.ac.uk/10.1016/S0262-4079(20)30790-9.
Article
PubMed
PubMed Central
Google Scholar
Ding T, Hardiman PJ, Petersen I, Wang FF, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017;8(56):96351–8.
Article
PubMed
PubMed Central
Google Scholar
Wang S, Alvero R. Racial and ethnic differences in physiology and clinical symptoms of polycystic ovary syndrome. Semin Reprod Med. 2013;31(5):365–9.
Article
PubMed
Google Scholar
Silberstein M. Vitamin D: a simpler alternative to tocilizumab for trial in COVID-19? Med Hypotheses. 2020;140:109767. https://0-doi-org.brum.beds.ac.uk/10.1016/j.mehy.2020.109767.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tian Y, Rong L. Letter: Covid-19, and vitamin D. Authors’ reply. Aliment Pharmacol Ther. 2020;51(10):995–996. doi: https://0-doi-org.brum.beds.ac.uk/10.1111/apt.15764.
Panarese A, Shahini E. Letter: Covid-19, and vitamin D. Aliment Pharmacol Ther. 2020;51(10):993–5. https://0-doi-org.brum.beds.ac.uk/10.1111/apt.15752.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rhodes JM, Subramanian S, Laird E, Kenny RA. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Aliment Pharmacol Ther. 2020. https://0-doi-org.brum.beds.ac.uk/10.1111/apt.15777.
Marik PE, Kory P, Varon J. Does vitamin D status impact mortality from SARS-CoV-2 infection? Med Drug Discov. 2020:100041. https://0-doi-org.brum.beds.ac.uk/10.1016/j.medidd.2020.100041.
Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):E988. https://0-doi-org.brum.beds.ac.uk/10.3390/nu12040988.
Article
PubMed
Google Scholar
Jakovac H. COVID-19 and vitamin D-is there a link and an opportunity for intervention? Am J Physiol Endocrinol Metab. 2020;318(5):E589. https://0-doi-org.brum.beds.ac.uk/10.1152/ajpendo.00138.2020.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020. https://0-doi-org.brum.beds.ac.uk/10.1007/s40520-020-01570-8.
Garg M, Al-Ani A, Mitchell H, Hendy P, Christensen B. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North - supports vitamin D as a factor determining severity. Authors’ reply. Aliment Pharmacol Ther. 2020. https://0-doi-org.brum.beds.ac.uk/10.1111/apt.15796.
Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz CL, et al. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr. 2020;14(4):561–5.
Article
PubMed
PubMed Central
Google Scholar
Muscogiuri G, Mitri J, Mathieu C, Badenhoop K, Tamer G, Orio F, et al. Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur J Endocrinol. 2014;171(3):R101–10.
Article
CAS
PubMed
Google Scholar
Reis GV, Gontijo NA, Rodrigues KF, Alves MT, Ferreira CN, Gomes KB. Vitamin D receptor polymorphisms and the polycystic ovary syndrome: a systematic review. J Obstet Gynaecol Res. 2017;43(3):436–46.
Article
PubMed
Google Scholar
Azadi-Yazdi M, Nadjarzadeh A, Khosravi-Boroujeni H, Salehi-Abargouei A. The effect of Vitamin D supplementation on the androgenic profile in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials. Horm Metab Res. 2017;49(3):174–9.
Article
CAS
PubMed
Google Scholar
Akbari M, Ostadmohammadi V, Lankarani KB, Tabrizi R, Kolahdooz F, Heydari ST, et al. The effects of Vitamin D supplementation on biomarkers of inflammation and oxidative stress among women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Horm Metab Res. 2018;50(4):271–9.
Article
CAS
PubMed
Google Scholar
Bailey CJ. Metformin: historical overview. Diabetologia. 2017;60(9):1566–76.
Article
CAS
PubMed
Google Scholar
Sharma S, Ray A, Sadasivam B. Metformin in COVID-19: a possible role beyond diabetes. Diabetes Res Clin Pract. 2020;164:108183. https://0-doi-org.brum.beds.ac.uk/10.1016/j.diabres.2020.108183.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020. https://0-doi-org.brum.beds.ac.uk/10.1016/S2213-8587(20)30152-2.
Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, et al. Guidelines for the management of diabetes services and patients during the COVID-19 pandemic. Diabet Med. 2020. https://0-doi-org.brum.beds.ac.uk/10.1111/dme.14316.
Drucker DJ. Coronavirus infections and type 2 diabetes—shared pathways with therapeutic implications. Endocr Rev. 2020;41(3):bnaa011. https://0-doi-org.brum.beds.ac.uk/10.1210/endrev/bnaa011.
Article
PubMed
Google Scholar
Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the experience of clinical immunologists from China. Clin Immunol. 2020;214:108393. https://0-doi-org.brum.beds.ac.uk/10.1016/j.clim.2020.108393.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kaiser UB, Mirmira RG, Stewart PM. Our response to COVID-19 as endocrinologists and diabetologists. J Clin Endocrinol Metab. 2020;105(5):dgaa148. https://0-doi-org.brum.beds.ac.uk/10.1210/clinem/dgaa148.
Article
PubMed
Google Scholar
Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020. https://0-doi-org.brum.beds.ac.uk/10.1056/NEJMoa2008975.
Sriram K, Insel PA. Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence. Clin Pharmacol Ther. 2020. https://0-doi-org.brum.beds.ac.uk/10.1002/cpt.1863.
Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin–angiotensin–aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020. https://0-doi-org.brum.beds.ac.uk/10.1056/NEJMoa2006923.
Zhang P, Zhu L, Cai J, Lei F, Qin J-J, Xie J, et al. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020. https://0-doi-org.brum.beds.ac.uk/10.1161/CIRCRESAHA.120.317134.
Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, et al. Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. https://0-doi-org.brum.beds.ac.uk/10.1001/jamacardio.2020.1855.
Sama IE, Ravera A, Santema BT, van Goor H, ter Maaten JM, Cleland J, et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors. Eur Heart J. 2020:ehaa373 https://0-doi-org.brum.beds.ac.uk/10.1093/eurheartj/ehaa373.
Kahal H, Kyrou I, Uthman O, Brown A, Johnson S, Wall P, et al. The association between obstructive sleep apnea and metabolic abnormalities in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep. 2018;41(7). https://0-doi-org.brum.beds.ac.uk/10.1093/sleep/zsy085.
Kahal H, Kyrou I, Uthman OA, Brown A, Johnson S, Wall PDH, et al. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep Breath. 2020;24(1):339–50.
Article
PubMed
Google Scholar
Lance C. PAP therapy increases the risk of transmission of COVID-19. Cleve Clin J Med. 2020. https://0-doi-org.brum.beds.ac.uk/10.3949/ccjm.87a.ccc003.
Baker JG, Sovani M. Case for continuing community NIV and CPAP during the COVID-19 epidemic. Thorax. 2020;75(5):368. https://0-doi-org.brum.beds.ac.uk/10.1136/thoraxjnl-2020-214913.
Article
PubMed
Google Scholar
Barker J, Oyefeso O, Koeckerling D, Mudalige NL, Pan D. COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life. Thorax. 2020;75(5):367. https://0-doi-org.brum.beds.ac.uk/10.1136/thoraxjnl-2020-214890.
Article
PubMed
Google Scholar
Craig S, West S. British Thoracic Society. Guidance regarding coronavirus (COVID-19) and obstructive sleep apnoea (OSA): for people who routinely use continuous positive airway pressure (CPAP), their families and health care workers, 2020. https://www.brit-thoracic.org.uk/media/455098/osa-alliance-cpap-covid-19-advice-20-3-20-v10.pdf. Accessed 20 May 2020.
Google Scholar
Naver KV, Grinsted J, Larsen SO, Hedley PL, Jørgensen FS, Christiansen M, et al. Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia. BJOG. 2014;121(5):575–81. https://0-doi-org.brum.beds.ac.uk/10.1111/1471-0528.12558.
Article
CAS
PubMed
Google Scholar
Bahri Khomami M, Joham AE, Boyle JA, Piltonen T, Silagy M, Arora C, et al. Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity-a systematic review, meta-analysis, and meta-regression. Obes Rev. 2019;20(5):659–74. https://0-doi-org.brum.beds.ac.uk/10.1111/obr.12829.
Article
PubMed
Google Scholar
Yu HF, Chen HS, Rao DP, Gong J. Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016;95(51):e4863. https://0-doi-org.brum.beds.ac.uk/10.1097/MD.0000000000004863.
Article
CAS
Google Scholar
Mills G, Badeghiesh A, Suarthana E, Baghlaf H, Dahan MH. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Hum Reprod. 2020:deaa099. https://0-doi-org.brum.beds.ac.uk/10.1093/humrep/deaa099.
Matar R, Alrahmani L, Monzer N, Debiane LG, Berbari E, Fares J, et al. Clinical presentation and outcomes of pregnant women with COVID-19: a systematic review and meta-analysis. Clin Infect Dis. 2020:ciaa828. https://0-doi-org.brum.beds.ac.uk/10.1093/cid/ciaa828.
Serafini G, Parmigiani B, Amerio A, Aguglia A, Sher L, Amore M. The psychological impact of COVID-19 on the mental health in the general population. QJM. 2020:hcaa201. https://0-doi-org.brum.beds.ac.uk/10.1093/qjmed/hcaa201.
Fletcher-Sandersjöö A, Bellander BM. Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review. Thromb Res. 2020;194:36–41. https://0-doi-org.brum.beds.ac.uk/10.1016/j.thromres.2020.06.027.
Article
CAS
PubMed
PubMed Central
Google Scholar
Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020;192:152–60. https://0-doi-org.brum.beds.ac.uk/10.1016/j.thromres.2020.05.039.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gariani K, Hugon-Rodin J, Philippe J, Righini M, Blondon M. Association between polycystic ovary syndrome and venous thromboembolism: a systematic review and meta-analysis. Thromb Res. 2020;185:102–8. https://0-doi-org.brum.beds.ac.uk/10.1016/j.thromres.2019.11.019.
Article
CAS
PubMed
Google Scholar
Mongioì LM, Barbagallo F, Condorelli RA, Cannarella R, Aversa A, La Vignera S, et al. Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model. Endocrine. 2020;68(3):467–70. https://0-doi-org.brum.beds.ac.uk/10.1007/s12020-020-02349-7.
Article
CAS
PubMed
PubMed Central
Google Scholar